{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:37Z","timestamp":1786986937133,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006399","name":"Spectrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cllc.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T02:11:22Z","timestamp":1564625482000},"page":"37-46.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Kyle G.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9605-7113","authenticated-orcid":false,"given":"Ahsan","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan B.","family":"Ludmir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Sepesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara A.","family":"Vaporciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Heymach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara B.","family":"Antonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2019.07.007_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib2","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/cncr.30058","article-title":"Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)","volume":"122","author":"Wong","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2019.07.007_bib3","doi-asserted-by":"crossref","first-page":"e28650","DOI":"10.1371\/journal.pone.0028650","article-title":"Microrna expression characterizes oligometastasis(es)","volume":"6","author":"Lussier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2019.07.007_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2018.06.105","article-title":"Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial","volume":"102","author":"Palma","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2019.07.007_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2019.07.007_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non\u2013small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2019.07.007_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/JTO.0000000000000673","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer","volume":"10","author":"Eberhardt","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib10","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cllc.2018.09.015","article-title":"Local consolidation therapy (LCT) after first line tyrosine kinase inhibitor (TKI) for patients with egfr mutant metastatic non\u2013small-cell lung cancer (NSCLC)","volume":"20","author":"Elamin","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2019.07.007_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/JTO.0b013e318262caf6","article-title":"Radical treatment of non\u2013small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase ii trial (nct01282450)","volume":"7","author":"De Ruysscher","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib13","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mdu370","article-title":"Phase ii study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients","volume":"25","author":"Collen","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ijrobp.2014.07.012","article-title":"Propensity score\u2013matched analysis of comprehensive local therapy for oligometastatic non\u2013small cell lung cancer that did not progress after front-line chemotherapy","volume":"90","author":"Sheu","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2019.07.007_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jtho.2018.05.019","article-title":"Consolidative local ablative therapy improves the survival of patients with synchronous oligometastatic NSCLC harboring egfr activating mutation treated with first-line EGFR-TKIS","volume":"13","author":"Xu","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib16","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non\u2013small cell lung cancer: long-term progression free and overall survival results of a multi-institutional phase II randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib17","first-page":"848","article-title":"Automated identification of postoperative complications within an electronic medical record using natural language processing","volume":"306","author":"Murff","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2019.07.007_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.athoracsur.2017.05.021","article-title":"Perioperative outcomes of patients undergoing lobectomy on clopidogrel","volume":"104","author":"Atay","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2019.07.007_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/aje\/kwt441","article-title":"Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence","volume":"179","author":"Carrell","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cllc.2019.07.007_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib21","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.cllc.2019.07.007_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.1991.9.1.191","article-title":"Median follow-up in clinical trials","volume":"9","author":"Shuster","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jtho.2017.04.011","article-title":"The IASLC Lung Cancer Staging Project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer","volume":"12","author":"Chansky","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib24","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jtho.2018.07.098","article-title":"Progression-free survival and overall survival beyond 5 years of NSCLC patients with synchronous oligometastases treated in a prospective phase II trial (NCT 01282450)","volume":"13","author":"De Ruysscher","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non\u2013small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2019.07.007_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/jtd.2017.02.21","article-title":"Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non\u2013small cell lung cancer? A meta-analysis","volume":"9","author":"Li","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.cllc.2019.07.007_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12885-016-2379-x","article-title":"Long-term outcomes in radically treated synchronous vs. Metachronous oligometastatic non\u2013small-cell lung cancer","volume":"16","author":"Fleckenstein","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cllc.2019.07.007_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2013.07.023","article-title":"Radical treatment of synchronous oligometastatic non\u2013small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors","volume":"82","author":"Griffioen","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2019.07.007_bib29","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1158\/1078-0432.CCR-17-3279","article-title":"Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti\u2013PD1-resistant lung tumor model","volume":"24","author":"Niknam","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2019.07.007_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cllc.2019.07.007_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2019.07.007_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jtho.2017.04.014","article-title":"Combined radiotherapy and anti\u2013PD-l1 antibody synergistically enhances antitumor effect in non\u2013small cell lung cancer","volume":"12","author":"Gong","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.07.007_bib33","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume":"74","author":"Dovedi","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2019.07.007_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/0008-5472.CAN-15-3142","article-title":"Suppression of type I IFN signaling in tumors mediates resistance to anti\u2013PD-1 treatment that can be overcome by radiotherapy","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2019.07.007_bib35","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2019.07.007_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40425-016-0156-7","article-title":"Current clinical trials testing the combination of immunotherapy with radiotherapy","volume":"4","author":"Kang","year":"2016","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.cllc.2019.07.007_bib37","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2019.07.007_bib38","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.cllc.2019.07.007_bib39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.18.01074","article-title":"Comparison of population-based observational studies with randomized trials in oncology","volume":"37","author":"Soni","year":"2019","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730419302116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730419302116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:10:03Z","timestamp":1761505803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730419302116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1525730419302116"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2019.07.007","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}